1. Home
  2. CBAN vs RZLT Comparison

CBAN vs RZLT Comparison

Compare CBAN & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Colony Bankcorp Inc.

CBAN

Colony Bankcorp Inc.

HOLD

Current Price

$18.25

Market Cap

282.0M

Sector

Finance

ML Signal

HOLD

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$1.84

Market Cap

187.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBAN
RZLT
Founded
1975
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
282.0M
187.3M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
CBAN
RZLT
Price
$18.25
$1.84
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$12.33
AVG Volume (30 Days)
87.1K
12.5M
Earning Date
01-21-2026
11-06-2025
Dividend Yield
2.48%
N/A
EPS Growth
26.78
N/A
EPS
1.59
N/A
Revenue
$122,550,000.00
N/A
Revenue This Year
$20.97
N/A
Revenue Next Year
$25.65
N/A
P/E Ratio
$11.66
N/A
Revenue Growth
12.48
N/A
52 Week Low
$13.99
$1.07
52 Week High
$18.80
$11.46

Technical Indicators

Market Signals
Indicator
CBAN
RZLT
Relative Strength Index (RSI) 67.56 24.57
Support Level $18.18 $1.07
Resistance Level $18.80 $2.25
Average True Range (ATR) 0.40 0.60
MACD 0.07 -0.77
Stochastic Oscillator 73.68 7.13

Price Performance

Historical Comparison
CBAN
RZLT

About CBAN Colony Bankcorp Inc.

Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Share on Social Networks: